RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Diabetic Cardiomyopathies
Accession: DOID:9006945
browse the term
Definition: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
Synonyms: exact_synonym: Diabetic Cardiomyopathy
xref: EFO:1001458 ; MESH:D058065
G
A2m
alpha-2-macroglobulin
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:21742475
RGD:10046044
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786
G
Ace
angiotensin I converting enzyme
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:22595130
RGD:9685456
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Acot1
acyl-CoA thioesterase 1
ISO
associated with type 2 diabetes mellitus
RGD
PMID:23226270
RGD:13831128
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Adipoq
adiponectin, C1Q and collagen domain containing
IEP
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adipor1
adiponectin receptor 1
IEP
associated with Diabetes Mellitus, Type2;mRNA, protein:decreased expression:heart, serum
RGD
PMID:24669271
RGD:8695938
NCBI chr13:48,411,438...48,431,251
Ensembl chr13:45,859,533...45,879,241
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP IDA
associated with Diabetes Mellitus, Experimental; mRNA, protein:increased expression:heart (rat)
RGD
PMID:23251674 PMID:23251674
RGD:7244283 , RGD:7244283
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29353218
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15587404 PMID:16025228
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
G
Akt1
AKT serine/threonine kinase 1
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18332268
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Atf6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
IEP ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16685413 PMID:21441944
RGD:6771209
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Atp7a
ATPase copper transporting alpha
treatment
IMP
RGD
PMID:24927960
RGD:11341676
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:71,094,202...71,198,354
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:21296063
RGD:10053697
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA ISO
associated with Diabetes Mellitus, Experimental associated with Diabetes Mellitus, Experimental;protein:increased phosphorylation:myocardium (mouse)
RGD
PMID:21296063 PMID:21474815
RGD:10053697 , RGD:11522727
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp12
caspase 12
treatment
IEP
associated with Experimental Diabetes Mellitus
RGD
PMID:26869403
RGD:13782171
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:28992627
RGD:13782299
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:28992627
RGD:13782299
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:28992627
RGD:13782299
Ensembl chr 5:154,109,046...154,126,626
G
Casq2
calsequestrin 2
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:21441944
RGD:6771209
NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:189,525,960...189,582,267
G
Casr
calcium-sensing receptor
IEP
protein:decreased expression:myocardium (rat)
RGD
PMID:22137362
RGD:7205677
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:64,235,251...64,304,811
G
Cfl1
cofilin 1
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:27576917
RGD:11568692
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:202,786,627...202,817,587
G
Ctnnb1
catenin beta 1
IEP
mRNA,protein:increased expression:heart
RGD
PMID:25586361
RGD:13524855
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ddit3
DNA-damage inducible transcript 3
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IEP
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
IEP
associated with Diabetes Mellitus, Experimental;mRNA:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193
RGD:10449013
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
H19
H19 imprinted maternally expressed transcript
ameliorates
IMP ISO
RGD
PMID:27796346 PMID:36044268 PMID:27903964
RGD:156430325 , RGD:156430337 , RGD:156451660
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hmox1
heme oxygenase 1
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:23853776 PMID:23453443
RGD:9586347 , RGD:10412713
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hsp90b1
heat shock protein 90 beta family member 1
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788
G
Hspa5
heat shock protein family A (Hsp70) member 5
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11375343
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf2r
insulin-like growth factor 2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36462176
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:47,979,109...48,067,501
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:23843977
RGD:7247697
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Ins1
insulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:6225876
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20828608
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:197,843,281...197,864,775
G
Klk1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16129698
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754
G
Lepr
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35235096
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Map3k7
mitogen activated protein kinase kinase kinase 7
IEP
associated with type 2 diabetes mellitus;protein:decreased expression:myocardium of ventricle (rat)
RGD
PMID:22146585
RGD:155883162
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:25907942
RGD:13800893
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mir140
microRNA 140
ameliorates
ISO
RGD
PMID:36044268 PMID:31078585
RGD:156430337 , RGD:329347833
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:35,465,577...35,465,675
G
Mtor
mechanistic target of rapamycin kinase
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Mylk2
myosin light chain kinase 2
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:9005973
RGD:1580244
NCBI chr 3:161,836,705...161,848,609
Ensembl chr 3:141,376,691...141,387,728
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment ameliorates
IEP ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:23453443 PMID:23353773 PMID:36044268
RGD:10412713 , RGD:10412721 , RGD:156430337
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nos3
nitric oxide synthase 3
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:29274332
RGD:13504685
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:32828943
RGD:405650202
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Nppa
natriuretic peptide A
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:23497378
RGD:7297056
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nrg1
neuregulin 1
treatment
IEP
associated with Diabetes Mellitus, Experimental;protein:decreased expresssion:left ventricle myocardium
RGD
PMID:22285193 PMID:32828943
RGD:10449013 , RGD:405650202
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ameliorates
ISO
RGD
PMID:36044268
RGD:156430337
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Pln
phospholamban
IEP
associated with Diabetes Mellitus, Experimental;protein:increased expression:heart left ventricle
RGD
PMID:22185592
RGD:7327207
NCBI chr20:33,166,512...33,182,241
G
Ppara
peroxisome proliferator activated receptor alpha
IDA
Strain: ZDF
RGD
PMID:19317897
RGD:5509944
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ryr2
ryanodine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16685413
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:58,389,925...58,975,142
G
Slc25a4
solute carrier family 25 member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18945756
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:46,072,939...46,076,733
G
Slc8a1
solute carrier family 8 member A1
treatment
IEP
RGD
PMID:27058979
RGD:13628396
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16980342
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Tert
telomerase reverse transcriptase
treatment
IEP
associated with Diabetes Mellitus, Type 2
RGD
PMID:21264070
RGD:11038677
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17909696
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Xdh
xanthine dehydrogenase
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:23843977
RGD:7247697
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all